Ignite Creation Date:
2024-05-06 @ 1:17 PM
Last Modification Date:
2024-10-26 @ 1:11 PM
Study NCT ID:
NCT03982264
Status:
UNKNOWN
Last Update Posted:
2019-06-11
First Post:
2019-06-05
Brief Title:
Endoscopic Treatment of Rectal Neuroendocrine TumorNET Less Than 10mm
Sponsor:
Nanfang Hospital Southern Medical University
Organization:
Nanfang Hospital Southern Medical University
Study Overview
Official Title:
Cap Endoscopic Mucosal ResectionEMR-C Versus Endoscopic Submucosal DissectionESD for Treatment of Rectal Neuroendocrine TumorNET Less Than 10mm
Status:
UNKNOWN
Status Verified Date:
2019-06
Last Known Status:
NOT_YET_RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Cap-assisted endoscopic mucosal resection EMR-C and endoscopic submucosal dissection ESD have both been reported to be effective treatment methods for small rectal neuroendocrine tumor NET in limited studies Which one is better has not been determined We aimed to compare the efficacy and safety of EMR-C and ESD for the treatment of small rectal NET
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None